Changes in the Number of Continuation Patents on Drugs Approved by the FDA

JAMA. 2023 Aug 1;330(5):469-470. doi: 10.1001/jama.2023.11525.
No abstract available

Plain language summary

This study assesses the frequency of continuation patents on brand-name drugs approved by the US Food and Drug Administration from 2000 to 2015.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Drug Approval / statistics & numerical data
  • Drug Costs* / statistics & numerical data
  • Drugs, Generic / therapeutic use
  • Economic Competition*
  • Patents as Topic* / statistics & numerical data
  • United States / epidemiology
  • United States Food and Drug Administration

Substances

  • Drugs, Generic